Advancements in bone graft substitutes has provided a better alternative to bone grafts for patients, however, high cost has limited its adoption among price sensitive customers. Developed regions such as North America and Europe have the presence of innovative product manufacturers in this product space. However, the costs of the products as well as the procedural costs for in the hospitals in these regions are comparatively higher than that in the emerging economies such as India, China, and Brazil which may prove to be the primary driving factor for growth in this market. According to OrthoStreams, orthopedic surgeries in China and other emerging economies are 75% cheaper as compared to that of the procedures performed in the U.S. Hospitals in emerging economies have access to advanced technologies and skilled surgeons to perform the procedure with the same level of precision as that in developed countries. Costs associated with any surgical procedures are lower in emerging economies such as India as overall cheaper costs for everything associated with such procedures depending on the complexity of the surgeries. Furthermore, hospitals use locally manufactured graft and graft substitutes for bone grafting procedures that provide equivalent levels of performance to that of the globally available commercial bone graft substitutes. According to the International Journal of Pharmaceutical Sciences Review and Research, 2015, dental surgeries cost three to four times more in developed regions than in India. Thus, a large patient pool migrates to India to avail bone grafting procedures, leading to growth of the dental bone graft and substitutes market in Asia Pacific.
Geographies Covered:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients